Answers are grounded in this paper and cite their sources.
: We find that the combination of microtubule stabilizing agent and lysosome inhibitor could reduce the tumor progression in EGFR TKI resistant mouse models of lung cancer.
No takes yet. Share an insight, caveat, or question.
Chin et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: